Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming (Q33936302)

30 July 2017

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming (English)

1 reference

30 July 2017

Wolfers J

1

1 reference

30 July 2017

Lozier A

2

1 reference

30 July 2017

Raposo G

3

1 reference

30 July 2017

Regnault A

4

1 reference

30 July 2017

Théry C

5

1 reference

30 July 2017

Masurier C

6

1 reference

30 July 2017

Flament C

7

1 reference

30 July 2017

Pouzieux S

8

1 reference

30 July 2017

Faure F

9

1 reference

30 July 2017

Tursz T

10

1 reference

30 July 2017

Angevin E

11

1 reference

30 July 2017

Amigorena S

12

1 reference

30 July 2017

Zitvogel L

13

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

30 July 2017

1 reference

30 July 2017

7

1 reference

30 July 2017

3

1 reference

30 July 2017

297-303

1 reference

https://scigraph.springernature.com/pub.10.1038/85438

30 July 2017

0 references

cites work

Human tumor antigens recognized by T lymphocytes

1 reference

7 January 2021

A new era for cancer immunotherapy based on the genes that encode cancer antigens

1 reference

7 January 2021

The makings of a tumor rejection antigen

1 reference

7 January 2021

The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection

1 reference

7 January 2021

A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation

1 reference

7 January 2021

B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes

1 reference

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

7 January 2021

Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response

1 reference

7 January 2021

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo

1 reference

7 January 2021

Heat shock proteins transfer peptides during antigen processing and CTL priming

1 reference

7 January 2021

Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations

1 reference

7 January 2021

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

7 January 2021

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 reference

7 January 2021

B lymphocytes secrete antigen-presenting vesicles

1 reference

7 January 2021

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

1 reference

7 January 2021

Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73.

1 reference

7 January 2021

Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes.

1 reference

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

7 January 2021

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

7 January 2021

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

1 reference

7 January 2021

BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line.

1 reference

7 January 2021

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

1 reference

7 January 2021

Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation

1 reference

7 January 2021

In situ demonstration of renal-cell-carcinoma-specific T-cell clones

1 reference

7 January 2021

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

1 reference

7 January 2021

Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface

1 reference

7 January 2021

Recycling MHC class I molecules and endosomal peptide loading

1 reference

7 January 2021

Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor

1 reference

7 January 2021

Exosomes released during reticulocyte maturation bind to fibronectin via integrin alpha4beta1

1 reference

7 January 2021

Immunotherapy with CTLs restricted by nonself MHC.

1 reference

7 January 2021

alphavbeta5 integrin recruits the CrkII-Dock180-rac1 complex for phagocytosis of apoptotic cells

1 reference

7 January 2021

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

1 reference

7 January 2021

Identifiers

DOI

10.1038/85438

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference